课题基金 / 基金详情

Mycobacterium Tuberculosis Cell Wall Assembly

Mycobacterium Tuberculosis Cell Wall Assembly
结核分枝杆菌细胞壁组装
批准号:
8938582
负责人:
Mary Jackson
金额:
$18.75万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-07-01 至 2017-06-30

项目摘要

项目成果

Mary Jackson的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
 DESCRIPTION (provided by applicant): The cell envelope of Mycobacterium tuberculosis (Mtb) is the basis of many of the physiological and pathogenic features of this bacterial pathogen and the site of susceptibility and resistance to many anti- tuberculosis drugs. In spite of being Gram-positive bacteria, mycobacteria are unique in having a cell wall devoid of (lipo)teichoic acids and instead containing a heteropolysaccharide known as the arabinogalactan (AG) covalently attached to peptidoglycan (PG). To this date, the cell wall ligase(s) responsible for the covalent attachment of these two macromolecules has/have defied definition. Despite the fundamental structural differences that exist between AG and wall teichoic acids (WTA), the structure of the unit linking AG to PG in mycobacteria shares similarities with the linker involved in the covalent attachment of WTA to PG in many Gram-positive bacteria. Enzymes of the widespread LytR-Cps2A-Psr (LCP) family were recently identified as the likely ligases mediating WTA-PG attachment in Bacillus subtilis and Staphylococcus aureus. We identified three LCP-like proteins in the genome of Mtb H37Rv, one of them mapping to an AG biosynthetic gene cluster. We here propose to use a combination of genetic and biochemical approaches to determine whether these three LCP homologs are the long sought mycobacterial cell wall ligases and to define their therapeutic potential. In particula, we will test whether two novel antibacterial compounds, caprazamycin B and CPZEN-45, products of a collaboration with the Institute of Microbial Chemistry (BIKAKEN, Tokyo, Japan) that inhibit mechanistically similar enzymes in mycobacterial cell wall assembly (MraY and WecA, respectively) may represent promising scaffolds for the future development of inhibitors targeting the assembly of the mycobacterial cell wall. Similar to the situation with WTA ligases, i is likely that the ligase(s) of Mtb interact(s) with other wall proteins to coordinate cell wall synthesis with cell elongation and cell division. The characterization of Mtb's ligase(s) therefore also represents an important first step toward the elucidation of this key aspect of the physiology of mycobacteria and the future design of innovative therapeutic strategies aimed at targeting cell elongation and division.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Repurposing antimalarials for the treatment of NTM infections
  • 批准号:
    10646331
  • 项目类别:
  • 资助金额:
    $66.63万
  • 财政年份:
    2022
  • 负责人:
    Mary Jackson
  • 依托单位:
Repurposing antimalarials for the treatment of NTM infections
  • 批准号:
    10494711
  • 项目类别:
  • 资助金额:
    $64.52万
  • 财政年份:
    2022
  • 负责人:
    Mary Jackson
  • 依托单位:
Assembly and export of mycobacterial lipoglycans
  • 批准号:
    10620764
  • 项目类别:
  • 资助金额:
    $60.09万
  • 财政年份:
    2021
  • 负责人:
    Mary Jackson
  • 依托单位:
Assembly and export of mycobacterial lipoglycans
  • 批准号:
    10291355
  • 项目类别:
  • 资助金额:
    $67.65万
  • 财政年份:
    2021
  • 负责人:
    Mary Jackson
  • 依托单位:
海外基金